Synthetic viability by BRCA2 and PARP1/ARTD1 deficiencies

Xia Ding(National Cancer Institute), Shyam K. Sharan(Frederick National Laboratory for Cancer Research)
Nature Communications
August 8, 2016
Cited by 139


Related Papers